Becton, Dickinson and Co - Strategy, SWOT and Corporate Finance Report
Summary
Becton, Dickinson and Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Becton, Dickinson and Co (BD or ‘the company’) is a medical technology company. It is engaged in the development, manufacturing and sale of medical devices, laboratory equipment and diagnostic products. The company’s major products include syringes and pen needles, intravenous catheters, infusion pumps and disposables, automated medication dispensing systems, respiratory ventilation and diagnostics equipment, diagnostics specimens, instruments to detect a broad range of infectious diseases, healthcare-associated infections and cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. It offers its products under SmartSite, BD Rowa, BD PosiFlush, BD Pyxis, and BD Neopak brand names. The company operates across the Americas, Europe, Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook